PR Log - Momentum Trade Alert on BioTechnology Power3 by rsg18606


									PR Log - Global Press Release Distribution Momentum Trade Alert on BioTechnology: Power3 Medical Products, Inc.
                                    OTCBB: PWRM

       Dated: Jan 02, 2010 issues technical and fundamental stock alerts. Investors that are looking to receive stock
       alerts on penny stocks can subscribe to our FREE Newsletter today. Issues Momentum Alert on Bio Technology: Power3 Medical Products, Inc. OTCBB:

        Power3 Medical Products, Inc. OTCBB: PWRM. The stock broke resistance at .14 on Friday and closed up
       13% on 4 million volume.

        About Power3 Medical Products, Inc.:

        Power3 Medical Products (OTCBB:PWRM) ( is a leading bio-medical
       company engaged in the commercialization of neurodegenerative disease and cancer biomarkers, pathways,
       and mechanisms of diseases through the development of diagnostic tests and drug targets. Power3's
       patent-pending technologies are being used to develop screening and diagnostic tests for the early detection
       and prognosis of disease, identify protein biomarkers, and drug targets. Diagnostic tests are targeted toward
       markets with critical unmet needs in areas including neurodegenerative disease (NuroPro(R)) and breast
       cancer (BC-SeraPro(TM)). Power3 expects to complete phase II clinical validation trials of its blood serum
       diagnostics for Alzheimer's disease (NuroPro-AD), Parkinson's disease (NuroPro-PD) and breast cancer in
       2010, followed by filings with the FDA. Power3 operates a state-of-the-art CLIA certified laboratory in The
       Woodlands (Houston), Texas. Power3 continues to evolve and enhance its IP portfolio, employing sensitive
       and specific combinations of biomarkers it has discovered from a broad range of diseases as the basis of
       highly selective blood-based tests for ALS, Alzheimer's, and Parkinson's diseases, and breast cancer.

        To Receive Our Newsletters Visit


        Information in emails, press releases, news distributions and content on
       website may contain “forward looking statements” in this action may be identified through the use of words
       such as “expects,” “will,” “anticipates,”estimates,” “believes,” “may,” or by statements indicating certain
       actions “may,” “could,” or “might” occur. Forward looking statements as defined under Section 27A of the
       Securities Act of 1933 and Section 21B,21E of the Securities Exchange Act of 1934. An example of
       forward-looking information are statements relating to the future anticipated direction of the industry, plans
       for future expansion, various business development activities, planned capital expenditures, future funding
       sources, anticipated sales growth and potential contracts. These and similar forward statements are subject
       to a number of known and unknown risks and uncertainties outside our control that could cause actual
       operations or results to differ materially from those anticipated.


                                                         Page 1/2
PR Log - Global Press Release Distribution


 We are an investor community and investors relations website specializing in emerging growth stocks in
today’s Hot Sectors and providing a platform of services for SmallCap, MicroCap, NanoCap Companies. is not a registered or licensed investment advisor. Our Full Disclaimer can be read at

Category           Advertising, Business
Tags               pennystocks, stock alerts, biotechnology, investors
Email              Click to email author
Address            288 Grove Street Suite 181
City/Town          Braintree
State/Province     Massachusetts
Zip                01284
Country            United States

                                                       Page 2/2

To top